Bayer’s Asundexian Reduces Recurrent Stroke Risk by 26 Percent in Landmark Phase III Trial

In OCEANIC-STROKE, patients who received asundexian after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack were significant...

February 10, 2026 | Tuesday | News
Bristol Myers Squibb Partners with Evinova to Advance AI Driven Clinical Trial Optimization

Agreement will leverage Evinova’s innovative AI-native platform to improve trial design, accelerate timelines, and enhance cost efficiency ...

February 10, 2026 | Tuesday | News
Peijia Medical Advances Global Expansion with EU MDR CE Mark Filing for GeminiOne TEER System

Peijia Medical Limited announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application fo...

February 10, 2026 | Tuesday | News
Genentech Advances Regulatory Path for Fenebrutinib After Phase III Success in Progressive MS

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority co...

February 09, 2026 | Monday | News
Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Konovo Acquires Rare Patient Voice to Deepen Access to Hard-to-Reach Rare Disease Communities

Rare Patient Voice’s 200,000+ registered patients and caregivers expand Konovo’s ability to deliver connected insights across a broad range o...

February 09, 2026 | Monday | News
Aminex Launches Mid-Stage Trial of Polyamine-Targeting Therapy in Solid Tumors

Novel approach attacks production of polyamines that tumors require to proliferate and suppress the immune system  Aminex Therapeutics, Inc., a...

February 06, 2026 | Friday | News
Forma Life Sciences Established Following Acquisition of BioDuro’s California Manufacturing Assets

BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm,  announced the successful acquisition of Bi...

February 06, 2026 | Friday | News
Cellares Expands Automation Platform into Gene-Edited HSC Therapies Through Stanford Medicine Collaboration

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announced a collaboration with the Stanford Center for Definitive and C...

February 05, 2026 | Thursday | News
Promega Secures NMPA Approval for OncoMate® MSI Detection Kit as Companion Diagnostic for KEYTRUDA® in China

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro...

February 05, 2026 | Thursday | News
Formerra Expands Distribution of Evonik CARE Brand Medical Grades Across U.S. and Canada

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada  Formerra, a leader in performance materials distribution, to...

February 05, 2026 | Thursday | News
insitro Uncovers Novel Peripheral Obesity Target Through AI-Enabled Brown Fat Genetics

AI-enabled brown adipose tissue (BAT) phenotype unlocks population-scale human genetic discovery BAT-01 knockdown drives 15% body-weight reduction in ...

February 04, 2026 | Wednesday | News
MedImpact Expands Health Solutions Platform With Sav-Rx Acquisition

Transaction expands MedImpact’s scale, expertise, and health solutions portfolio while maintaining Sav-Rx’s mission and service model ...

February 03, 2026 | Tuesday | News
Trace Biosciences Receives FDA IND Clearance for First Nerve-Specific Fluorescent Imaging Agent

Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents,  announced that the U.S. Food and Drug Adm...

February 03, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close